Repository logo
  • AI Search Assistant Beta
    • English
    • 中文
    Log In
    Have you forgotten your password?
    1. Home
    2. College of Medicine / 醫學院
    3. School of Medicine / 醫學系
    4. Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan
     
    • Details

    Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan

    Journal
    Cardiovascular Drugs and Therapy
    Journal Volume
    16
    Journal Issue
    3
    Pages
    221
    Date Issued
    2002
    Author(s)
    KUO-LIONG CHIEN  
    Huang P.-J.
    MING-FONG CHEN  
    FU-TIEN CHIANG  
    LING-PING LAI  
    Lee Y.-T.
    DOI
    10.1023/A:1020648405680
    URI
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036438462&doi=10.1023%2fA%3a1020648405680&partnerID=40&md5=e0e52a37da9815bed8dcbaaadf4b7e8c
    https://scholars.lib.ntu.edu.tw/handle/123456789/536730
    http://ntur.lib.ntu.edu.tw//handle/246246/81663
    Abstract
    Purpose. Although the role of angiotensin-converting enzyme (ACE) inhibitors for the treatment of hypertension has been well established, no data has been generated regarding the influence of ACE inhibitors for health-related quality-of-life (QOL) dimensions for Chinese patients. Materials. A double-blind, active-control, randomized clinical trial was used to compare the effects of two ACE inhibitors, imidapril and captopril, on quality-of-life dimensions in one outpatient clinic in one tertiary clinical-care facility. After a 2-3 week washout period with placebo, 59 patients with mild-to-moderate hypertension were randomly assigned to receive imidapril (5 to 10 mg per day) or captopril (25 to 50 mg twice per day) for 12 weeks. Patients completed the Short-form 36 (SF 36) health survey questionnaire, which evaluates 8 QOL dimensions, just before treatment, during the 8th week, and at the end of treatment (12th week). ANOVA for repeated measures was used to analyze the QOL-score changes over time and compare treatments, and to assess the interaction of treatment duration and group on these scores. Results. No significant differences were demonstrated for changes in blood-pressure, frequency of adverse effects and withdrawal of patients from the study comparing the two drugs. Significant improvement, however, was demonstrated for mental-component summary scores after 12 weeks of treatment for both drugs (P = 0.029). No significant differences were established for individual QOL dimensions comparing the two drugs. A significantly higher baseline systolic blood pressure was found in the participants who did not complete the questionnaire than in those who did. Conclusions. Similar and significant improvements were determined for the mental-component QOL summary scores for the two ACE inhibitors, imidapril and captopril, and no significant differences were demonstrated comparing treatments.
    SDGs

    [SDGs]SDG3

    Other Subjects
    aminotransferase; captopril; dipeptidyl carboxypeptidase inhibitor; imidapril; captopril; dipeptidyl carboxypeptidase inhibitor; imidapril; imidazole derivative; imidazolidine derivative; adult; aged; aminotransferase blood level; article; Chinese; clinical trial; controlled clinical trial; controlled study; coughing; double blind procedure; drug efficacy; drug safety; drug withdrawal; female; human; hypertension; major clinical study; male; priority journal; proteinuria; quality of life; randomized controlled trial; systolic blood pressure; Taiwan; treatment outcome; Asian; blood pressure; comparative study; drug effect; ethnology; hypertension; middle aged; psychological aspect; quality of life; questionnaire; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Asian Continental Ancestry Group; Blood Pressure; Captopril; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Imidazolidines; Male; Middle Aged; Quality of Life; Questionnaires; Taiwan; Treatment Outcome
    Type
    journal article
    File(s)
    Loading...
    Thumbnail Image
    Name

    26.pdf

    Size

    88.75 KB

    Format

    Adobe PDF

    Checksum

    (MD5):5bfb29da888771220cee77068c8c0828

    臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

    To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

    總館學科館員 (Main Library)
    醫學圖書館學科館員 (Medical Library)
    社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

    開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

    • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
      Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
    • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
      Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
    • 網站簡介 (Quickstart Guide)
    • 使用手冊 (Instruction Manual)
    • 線上預約服務 (Booking Service)
    • 方案一:臺灣大學計算機中心帳號登入
      (With C&INC Email Account)
    • 方案二:ORCID帳號登入 (With ORCID)
    • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
    • 方案二:自行建檔 (Default mode Submission)
    • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

    Built with DSpace-CRIS software - Extension maintained and optimized by 4Science